Veos Pharmaceuticals Selected to Present at Europe–Japan SALON Part 4, Showcasing OliQuell™ for Green Innovation
Veos to present its breakthrough olive-waste-derived platform at Tokyo event organized by SAKURA DEEPTECH Shibuya and the EU–Japan Centre for Industrial Cooperation.
Madrid, Spain — August 21, 2025 — Veos Pharmaceuticals is proud to announce its selection to present at the Europe–Japan SALON Part 4, organized by SAKURA DEEPTECH Shibuya and the EU–Japan Centre for Industrial Cooperation, under the EU Business Hub. The event will be held in Tokyo, Japan, on September 3, 2025, and will bring together leading European and Japanese startups, corporates, and policymakers with a focus on GREEN innovation.
OliQuell™ — Nature-Based Green Solutions
Veos Pharma will present OliQuell™, its breakthrough, nature-based platform derived from olive waste that provides scalable solutions for:
- Water purification & reuse: Removing turbidity, heavy metals, agrochemicals, and stabilizing pH.
- Biogas purification: Reducing methane (–84%) and hydrogen sulfide (–81%), while boosting oxygenation.
- Air & emissions control: Cutting CO₂ (–50%) and VOCs, validated in pilots with Volvo, Zeekr, and IMDEA.
reduction
reduction
reduction
With proven results in Europe, Africa, and Asia, OliQuell™ aligns with Japan's GX 2030 decarbonization goals, offering a circular, chemical-free, and cost-effective alternative to traditional filtration and chemical flocculants.
"We are honored to bring Mediterranean innovation to Japan's stage at Europe–Japan SALON. OliQuell™ demonstrates how nature-based solutions can drive water security, clean air, and industrial sustainability in line with Japan's green transition goals." — Dr. Bassam Damaj, CEO of Veos Pharmaceuticals
Building Strategic Partnerships in Japan
Veos Pharmaceuticals looks forward to building strategic partnerships in Japan across the water, biogas, and filtration sectors to support sustainable growth and cross-border collaboration.
Event Details
📍 Location: Tokyo, Japan
🕔 Time: 5:00–7:30 PM JST
About Veos Pharmaceuticals
Headquartered in Madrid, Spain, Veos Pharmaceuticals S.L. is a global biotechnology company with a portfolio of nearly 40 products across the EU, US, and Canada. The company specializes in OTC solutions, biostimulants, and advanced nutritional products aimed at improving quality of life.
Veos Pharma's flagship products include Ocufresh®, BioPropello™, OliQuell™, OleoSorb™, VEOX-Preserve™, and ThymoTropin™.
For more information, visit www.veospharma.com.
Media & Investor Contact
Veos Pharmaceuticals, S.L.
Calle Núñez de Balboa, 35 A-5 Planta Oficina A1
28001 Madrid, Spain
Email: info@veospharma.com
Telephone: +34 911 925 649
Website: www.veospharma.com